Sepracor Xopenex Expanded Sales Force Will Focus on Managed Care
Sepracor will increase its Xopenex sales force by 350 reps as a part of a reorganizational shift to focus on managed care and Medicare.
You may also be interested in...
Sepracor will use its 450-person Xopenex sales force to detail MedPointe's Astelin under a copromotion agreement for the antihistamine
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011